Allopregnanolone modulates striatal dopamingergic activity of rats under different gonadal hormones conditions

References

• Bazzett TJ, Becker JB. Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Res 1994; 637: 163–172
   PubMed Web of Science ®Google Scholar
• Dluzen DE, Ramirez VD. In vitro progesterone modulation of amphetamine-stimulated dopamine release from the corpus striatum of ovariectomized estrogen-treated female rats: Response characteristics. Brain Res 1990; 517: 117–122
   PubMed Web of Science ®Google Scholar
• Becker JB, Robinson TE, Lorenz KA. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur J Pharmacol 1982; 80: 65–72
   PubMed Web of Science ®Google Scholar
• Becker JB, Cha JH. Estrous cycle-dependent variation in amphe-tamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 1989; 35: 117–125
   PubMed Web of Science ®Google Scholar
• Di Paolo T, Falardeau P, Morissette M. Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci 1988; 43: 665–672
   PubMed Web of Science ®Google Scholar
• Levesque D, Di Paolo T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol. Neurosci Lett 1988; 88: 113–118
   PubMed Web of Science ®Google Scholar
• Joyce JN, Van Hartesveldt C. Estradiol application to one striatum produces postural deviation to systemic apomorphine. Pharmacol Biochem Behav 1984; 20: 575–581
   PubMed Web of Science ®Google Scholar
• Robinson TE, Camp DM, Becker JB. Gonadectomy attenuates turning behavior produced by electrical stimulation of the nigrostriatal dopamine system in female but not male rats. Neurosci Lett 1981; 23: 203–208
   PubMed Web of Science ®Google Scholar
• Melamed E, Hefti F, Wurtman RJ. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions. Proc Natl Acad Sci USA 1980; 77: 4305–4309
   PubMed Web of Science ®Google Scholar
• Castner SA, Xiao L, Becker JB. Sex differences in striatal dopamine: In vivo microdialysis and behavioral studies. Brain Res 1993; 610: 127–134
   PubMed Web of Science ®Google Scholar
• Baulieu EE. Neurosteroids: Of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 1997; 52: 1–32
   PubMedGoogle Scholar
• Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepian-drosterone sulfate as neuroactive neurosteroids. J Endocrinol 1996; 150: S221—S239
   PubMed Web of Science ®Google Scholar
• Majewska MD. Neurosteroids: Endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992; 38: 379–395
   PubMed Web of Science ®Google Scholar
• Corpechot C, Young J, Clavel, et al. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 1993; 133: 1003–1009
   PubMed Web of Science ®Google Scholar
• Cabrera RJ, Bregonzio C, Laconi, MR, et al. Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent. Cell Mol Neurobiol 2002; 22: 445–454
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd edn, Orlando, FL: Academic Press, 1986
   Google Scholar
• Laconi MR, Casteller G, Gargiulo PA, etal. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur J Pharmacol 2001; 417: 111–116
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AJ, et al. Protein measurement with folin phenol reagent. J Biol Chem 1951; 153: 265–275
   Google Scholar
• Kalia V, Fenske C, Hole DR, et al. Effect of gonadal steroids and gamma-aminobutyric acid on LH release and dopamine expression and activity in the zona incerta in rats. I Reprod Fertil 1999; 117: 189–197
   PubMedGoogle Scholar
• Cabrera RJ, Diaz A, Pinter A, et al. In vitro progesterone effects on 3H dopamine release from rat corpus striatum slices obtained under different endocrine conditions. Life Sci 1993; 53: 1767–1777
   PubMed Web of Science ®Google Scholar
• Majewska MD, Demirgoren S, London ED. Binding of pregnenolone sulfate to rat brain membranes suggests multiple sites of steroid action at the GABAA receptor. Eur J Pharmacol 1990; 189: 307–315
   PubMed Web of Science ®Google Scholar
• Fuxe K, Agnati LF, Bolme P, et al. The possible involvement of GABA mechanisms in the action of benzodiazepines on central catecholamine neurons. Adv Biochem Psychopharmacol 1975; 14: 45–61
   PubMedGoogle Scholar
• Motzo C, Porceddu ML, Dazzi L, et al. Enhancement by flumazenil of dopamine release in the nucleus accumbens of rats repeatedly exposed to diazepam or imidazenil. Psychopharmacology (Berl) 1997; 131: 34–39
   PubMed Web of Science ®Google Scholar
• Cabrera, RJ, Navarro CE. Progesterone in vitro increases NMDA-evoked [3H] dopamine release from striatal slices in proestrus rats. Neuropharmacology 1996; 35: 175–178
   PubMed Web of Science ®Google Scholar
• Maurice T, Roman FJ, Privat A. Modulation by neurosteroids of the in vivo (±)-13HISKF-10,047 binding to sigma 1 receptors in the mouse forebrain. Neurosci Res 1996; 46: 734–743
   Web of Science ®Google Scholar
• Reddy DS, Kaur G, Kulkarni SK. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport 1998; 9: 3069–3073
   PubMed Web of Science ®Google Scholar
• Mohan-Kumar PS, Thyagarajan S, Quadri SK. Cyclic and age-related changes in norepinephrine concentrations in the medial preoptic area and arcuate nucleus. Brain Res Bull 1995; 38: 561–564
   PubMed Web of Science ®Google Scholar
• McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991; 12: 141 —144
   Google Scholar
• Murakami K, Fellous A, Baulieu E. Pregnenolone binds to microtubule-associated protein 2 and stimulates microtubule assembly. Proc Natl Academ Sci USA 2000; 97: 3579–3684
   PubMed Web of Science ®Google Scholar
• Baulieu EE, Robel P, Fellous A, et al. MAPREG: Toward a novel approach of neuroprotection and treatment of Alzheimer's disease. J Mol Neurosci 2004; 24: 63–65
   PubMed Web of Science ®Google Scholar